Tuberculosis of the Cuboid Bone: An Unfamiliar Manifestation of a Familiar Disease Authors: Morteza Pourahmad, Hosein Nouri, Behrooz Ataei, Ghazaal Alavi Tabatabaei, Gholam Ali Hoghooghi, Milad Rayani Published: 2025 ABSTRACT This report discusses a patient with chronic ankle pain for 2 years. No respiratory symptoms were present, but her father had tuberculosis (TB) when she was four. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were elevated. Empirical antibiotic therapy was initiated. The viral panel test was negative, while the purified protein derivative (PPD) test showed >20 mm induration. Chest radiograph and computed tomography (CT) scan were normal. Ankle radiograph revealed hypodense areas, osteolytic changes, and soft tissue swelling in the cuboid bone. Magnetic resonance imaging (MRI) confirmed soft tissue signal in the cuboid bone. Biopsy showed non-caseating necrotizing granulomatous reaction. The polymerase chain reaction (PCR) and culture confirmed M. tuberculosis infection. Anti-TB treatment was initiated.Skeletal TB in peripheral bones is very rare. Early-stage diagnosis can be challenging due to various potential causes, leading to irreversible complications. Thus, a high index of clinical suspicion should always be maintained. Imaging findings may be suggestive but not confirmative. INTRODUCTION According to the World Health Organization (WHO), tuberculosis (TB) claims over a million lives annually and causes significant global morbidity. Developing and underdeveloped countries with higher poverty rates bear a greater disease burden.[1] Mycobacterium tuberculosis (M. tuberculosis) has infected an estimated 1.7 billion people worldwide, mostly in latent form without clinical or radiological signs.[2] Immunocompromised individuals may experience bacterial reactivation, known as “secondary TB,” which presents diverse clinical symptoms depending on the affected anatomical site.[3] Approximately 15% of active TB cases involve extrapulmonary TB (EPTB), with bone and joint involvement occurring in 10% of EPTB cases.[4] Pott’s disease—that is, TB spondylitis—is the most familiar form of skeletal TB, but M. tuberculosis can virtually seed into any bone and later give rise to extraspinal osteomyelitis therein.[3] Foot or ankle TB is uncommon and comprises 8–10% of skeletal TB cases, that is, only 0.1–0.3% of EPTB cases; talus and calcaneus are the most commonly affected bones.[5] TB involvement of other bones in the foot is extremely rare, usually manifests as a cold abscess, and often proves a quite challenging diagnosis; it necessitates a high suspicion index and meticulous diagnostic workup. We present the first case of cuboid tubercular osteomyelitis in Iran and draw the readership’s attention to the wide variety of skeletal involvement patterns that one should expect of M. tuberculosis. CASE REPORT A 44-year-old woman presented with a 2-year history of left ankle pain in January 2023. The pain worsened 3 months ago, accompanied by swelling and redness. Weight-bearing aggravated the dull pain, rendering her unable to walk independently. She had no fever, weight loss, night sweats, or back pain. On examination, there was swelling on the dorsolateral side of her foot, which was tender but non-pulsatile. No neurological or lymph node abnormalities were detected. Her medical history was unremarkable, except for her father’s previous TB when she was four. She had no smoking, alcohol, or use of illicit drugs. She was hospitalized for further evaluation and possible surgery. Initial blood tests showed an elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and normal results otherwise. Empirical antibiotic therapy—cefepime and vancomycin—was initiated. Viral panel tests returned non-reactive. Wright, Coombs Wright, and 2-mercaptoethanol (2-ME) tests returned negative. The purified protein derivative (PPD) test was positive. Imaging revealed osteolytic changes in the cuboid bone [Figure 1]. Biopsy confirmed non-caseating necrotizing granulomatous reaction [Figure 1]. Based on the pathological findings and clinical evidence, malignancies were ruled out. Polymerase chain reaction (PCR) test and culture confirmed secondary skeletal TB. Anti-TB treatment was started with an intensive phase regimen of isoniazid, rifampicin, pyrazinamide, and ethambutol, in addition to pyridoxine. a. Anterior-posterior (AP) radiograph of the foot showing hypodense areas and osteolytic changes along the cuboid bone, with soft tissue swelling and inflammation. b. Biopsy sample showing non-caseating granuloma and c. multinucleated giant cells and macrophages. Non-caseating granuloma is another atypical feature of TB that is rarely seen The patient was followed up for 6 months. Her clinical symptoms were completely resolved after 4 months from treatment initiation. All laboratory tests, examinations, and imaging studies of the patient at the end of the 6-month follow-up period were normal. She did not report any adverse drug effects. DISCUSSION TB is a significant health concern, the second leading cause of death after human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) among infectious diseases.[6] Skeletal TB affecting the foot and ankle is an uncommon form of EPTB that can be challenging to diagnose and easily mistaken for other conditions. Differential diagnoses include pyogenic arthritis, traumatic arthritis, rheumatoid arthritis, fungal arthritis, bone tumors, and even Kaposi’s sarcoma.[7] For pyogenic bone infection, suggestive features include a high fever and acuteness (within a few hours of infection) of symptoms, such as local pain and warmth around the joints. However, imaging cannot conclusively distinguish between skeletal TB and pyogenic infection, whereas its role in differentiating rheumatoid arthritis is more pronounced, given its associated characteristic findings, such as synovial thickening and involving peripheral joints; TB of the bone, however, often shows more severe erosion, a rim pattern of enhancement, and extra-articular cystic masses.[8] A characteristic finding suggestive of fungal arthritis is high signal intensity rim on T1-weighted images and sinus tract formation, which can be appreciated as linear hyperintensities on T2-weighted image scans with marginal tram track enhancement. In contrast, soft tissue collections with rim enhancement are rarely seen in skeletal TB.[910] Differentiating bone TB from tumors cannot rely solely on clinical and imaging findings, with both entities manifesting through joint pain, swelling, effusion, stiffness, or limitation of movement and showing osteolytic or sclerotic changes on radiographs.[11] Nevertheless, an open biopsy is the gold standard test to rule out latent TB. Our literature search yielded six cases of skeletal TB in the cuboid bone [Table 1], predominantly in female patients (n = 5). Pain and swelling in the anterolateral area of the affected foot were common symptoms. Osteolytic lesions were observed in all cases, with one exhibiting a patchy pattern (case no. 3). Positive PPD test results were obtained in adults, except for one pediatric patient.[12] All three patients whose histopathological study results were reported had granulomatous necrosis—a diagnostic pattern for TB. Table 1Clinical features and treatment regimens for cuboid TBCase no. (ref)Age/sexClinical/radiological featuresLaboratory dataHistopathological patternTreatment (duration)/outcome1 (7)39/FPain, swelling/no CT or MRI findings reported↑ESR, PPD+NR(INH + RIF + EMB) (3 m) + (INH + RIF) (12 m)/treated2 (7)24/MPain, swelling, low fever/osteolytic lesions (on radiography)↑ESR, PPD+NR(INH + RIF + EMB + PZA) (4 m) + (INH + RIF) (14 m) /treated3 (7)33/FPain, swelling, fever/patchy lesions (on radiography), abnormal signal changes in MRI↑ESR, PPD+NR(INH + RIF + EMB + PZA) (4 m) + (INH + RIF) (13 m) /Treated4 (7)20/FPain/osteolytic lesions (on radiography), abnormal signal changes in MRI↑ESR, PPD+NR(INH + RIF + EMB + PZA) (3 m) + debridement and external fixator (2 m) /treated5 (6)44/FPain, swelling/osteolytic lesions (on radiography), abnormal signal changes in MRI↑ESR, PPD+, ↑CRPGranulomas with caseous necrosis, acid-fast bacilli detected(INH + RIF + EMB + PZA) (2 m) + (INH + RIF) (4 m) /treated6 (12)1/FPain, swelling, fever/osteolytic lesions (on radiography)↑ESR, PPD-Granulomas with necrosis(INH + RIF + PZA) (12 m) + Debridement and curettage of the cystic lesion/treated7 (our case)44/FPain, swelling/osteolytic lesions (on radiography), abnormal signal changes in MRI↑ESR, PPD+, ↑CRPgranuloma with necrosis(INH + RIF + EMB + PZA)(2 m) + (INH + RIF) (6M)/treatedF, female; m, month (s); M, male; NR, not reported Clinical features and treatment regimens for cuboid TB F, female; m, month (s); M, male; NR, not reported A negative Mantoux test, absence of fever, and normal ESR do not exclude the diagnosis of skeletal TB. Computed tomography (CT) scan and magnetic resonance imaging (MRI) have a key role in early diagnosis, revealing severe osteoporosis in adjacent infectious focus and bone marrow edema with high signal changes in T2-weighted images. CT scans provide information on lesion extension.[10] Surgical exploration and biopsy are necessary for pathological studies and definitive diagnosis. Although TB usually presents as a caseous granuloma, there are rare instances where it can appear as a non-caseous granuloma. However, diagnosis can still be confirmed through culture and PCR testing. Standard treatment involves a 6- to 9-month course of anti-TB chemotherapy, with the possibility of extension if rifampicin is removed. Initial phase regimens typically consist of three or four drugs, while maintenance phase regimens involve two. Rifampicin (RIF), ethambutol (EMB), isoniazid (INH), and pyrazinamide (PZA) are commonly used in these regimens.[13] CONCLUSION Skeletal TB is a rare but important disease. Timely and suitable drug therapy is crucial to prevent permanent musculoskeletal damage. Early diagnosis can be achieved through high index of suspicion, history, laboratory tests, and imaging. Physicians should consider skeletal TB in patients with local pain/swelling, slow progression, and MRI/CT findings of tissue signal changes or bone erosion. Ethics approval and consent to participate The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published, and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed. Consent for publication Written informed consent was obtained from the patient for the publication of her anonymized data. Conflicts of interest There are no conflicts of interest.